SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-23-045091
Filing Date
2023-09-25
Accepted
2023-09-25 16:05:20
Documents
5
Period of Report
2023-10-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20010630x2_def14a.htm DEF 14A 261459
2 logo_ikena.jpg GRAPHIC 34202
3 ny20010630x2_pc-1.jpg GRAPHIC 575109
4 ny20010630x2_pc-2.jpg GRAPHIC 531777
5 sig_markmanfredi.jpg GRAPHIC 18710
  Complete submission text file 0001140361-23-045091.txt   1858734
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Filer) CIK: 0001835579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40287 | Film No.: 231275913
SIC: 2836 Biological Products, (No Diagnostic Substances)